Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034065 (
pulmonary embolism
)
14,979
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, we aimed to develop a thrombus-targeting delivery system of
collagenase
bound to a monoclonal antibody, and to investigate the thrombolysis of an immune-conjugate in vitro and in vivo as well as the targeting effect. We prepared the immunizing conjugation of
collagenase
by the 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDCI) method. In order to conjugate
collagenase
and a monoclonal antibody, bovine serum albumin was used as a linker, increasing the number of
collagenase
molecules carried and keeping
collagenase
and the monoclonal antibody active. In vitro thrombolysis experiments showed that
collagenase
had a strong dissolving effect on collagen-embolus within 24 hours. We established a rabbit
pulmonary embolism
model to investigate the thrombolysis effect of
collagenase
and
collagenase
immunizing conjugation in vivo. Our results revealed a significant difference between
collagenase
and
collagenase
immunizing conjugation (P < 0.05). We also established a rabbit ear edge vein model to investigate the active target of
collagenase
immunizing conjugation. We found that
collagenase
immunizing conjugation had active targets, and had a strong ability to dissolve organized thrombi. In conclusion, the thrombus-targeting delivery system of
collagenase
we developed has active targeting effects on thrombi.
...
PMID:Immunotargeting of collagenase on thrombus. 2118 49